This prediction was rigorously verified by Western blot experiments: IPTF can specifically inhibit the activation of key phosphorylation sites of AKT (Ser473), EGFR (Tyr1068), and ERK (Tyr204), thereby synergistically blocking the malignant proliferation process of tumor cells. Here, EGFR is linked to neoplasm.